[Ip-health] They opposed Novartis on Glivec, but now seek patent

[Joana Ramos]

http://www.dnaindia.com/report.asp?newsid=1260922


They opposed Novartis on Glivec, but now seek patent
Priyanka Golikeri
Tuesday, June 2, 2009 2:12 IST


Mumbai: If you thought only multinational drugmakers were monopolistic
and fought fiercely to secure patents for new forms of known molecules,
you are so wrong.

Indian pharma companies are just as aggressively chasing patents for
their versions of known drugs........


<snip>


........ the very same Indian companies are now looking to do a Novartis
themselves. Natco and Sun, among a host of others, which had opposed the
patent application of Novartis, are seeking patents for their versions
of the same molecule --- imatinib mesylate........


-------------------------
Joana Ramos, MSW
Cancer Resources & Advocacy
Seattle WA USA
+1-206-229-2420
http://ramoslink.info/
www.bmtbasics.org
www.healthyskepticism.org